# FUS Etoposide for DMG

> **NCT05762419** · PHASE1 · RECRUITING · sponsor: **Columbia University** · enrollment: 10 (estimated)

## Conditions studied

- Diffuse Intrinsic Pontine Glioma
- Diffuse Midline Glioma, H3 K27M-Mutant

## Interventions

- **DRUG:** Etoposide; Oral, 50 Mg
- **DEVICE:** Focused ultrasound with neuro-navigator-controlled sonication

## Key facts

- **NCT ID:** NCT05762419
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-05
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05762419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05762419, "FUS Etoposide for DMG". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05762419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*